Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy, Sell, Hold: 6 stocks being tracked by analysts today

      Cipla, Indian Oil, and Britannia, among others are on the radar of analysts today.

    • Hold Cipla, may test Rs 600: Rajesh Agarwal

      Rajesh Agarwal of AUM Capital is of the view that one may hold Cipla.

    • Buy Cipla at around Rs 400, says Rajat Bose

      Rajat Bose of rajatkbose.com advises buying Cipla at around Rs 400.

    • Why did pharmaceutical stocks take a hit today?

      Individual news flow along with negative outlook for the sector by Credit Suisse hit the sector. Frontline stocks tank, pulling down the markets further.

    • Sell Just Dial, Cipla: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can sell Just Dial and Cipla.

    • Buy ITC, Petronet LNG, Cipla; sell BPCL: Chandan Taparia

      Chandan Taparia of Motilal Oswal Securities recommends buying ITC, Petronet LNG and Cipla and suggests selling BPCL.

    • Bull's Eye: Buy Cipla, Eveready, Emami, Concor, Godrej, EIH, Fortis Health

      Jay Thakkar of Sharekhan advises buying Bliss GVS Pharma with a target of Rs 187.

    • Sell Cipla, buy Mangalore Refineries & Petrochemicals: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can sell Cipla and buy Mangalore Refineries & Petrochemicals.

    • Sell Kaveri Seed, Colgate, Cipla; buy M&M, DCB Bank: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com suggests selling Kaveri Seed Company, Colgate Palmolive (India) and Cipla and advises buying Mahindra and Mahindra and DCB Bank.

    • Resistance for bank Nifty at 22850; Tech Mahindra, Cipla bullish plays: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, Nifty has support at 9340 and resistance at 9500 while Bank Nifty has support at 22500 and resistance at 22850.

    • Cipla may test Rs 576, Rallis India Rs 260: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, Cipla may test Rs 576 while Rallis India may hit Rs 260.

    • Buy Infosys, TCS, HCL Tech, IRB Infrastructure; sell Cipla: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Infosys, Tata Consultancy Services, HCL Technologies and IRB Infrastructure and can sell Cipla.

    • Buy Colgate Palmolive, Coffee Day, MMTC, Rolta India; sell Cipla: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Colgate Palmolive, Coffee Day, MMTC and Rolta India and sell Cipla.

    • Buy Shipping Corporation of India; sell Cipla: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can buy Shipping Corporation of India and sell Cipla.

    • Buy M&M Financial; sell Cipla; RIL may test Rs 2200 in 12-15 months: Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can buy M&M Financial Services and sell Cipla while he feels that Reliance Industries may test Rs 2200 in 12-15 months.

    • Buy Canara Bank, IGL, Power Grid; sell Bharat Financial, Cipla: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can buy Canara Bank, Indraprastha Gas and Power Grid and sell Bharat Financial Inclusion and Cipla.

    • Buy Engineers India; sell Cipla: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can buy Engineers India and sell Cipla.

    • Buy, Sell, Hold: 9 stocks, 1 sector on analysts' radar as April series begins

      From Cipla to Yes Bank and Power Grid, a look at what brokerages are talking about these stocks.

    • Prefer Cipla, Aurobindo Pharma: Gaurang Shah

      According to Gaurang Shah of Geojit Financial Services, one may prefer Cipla and Aurobindo Pharma.

    • Here’s why JPMorgan has a neutral rating on Cipla

      JPMorgan believes that Cipla has the right moving parts in the earnings growth story, but will likely be moderate in the near term. The research firm has a neutral call on the stock with a target price of Rs 575.

    • Buy, Sell, Hold: Which stocks are analysts tracking today?

      Morgan Stanley has initiated coverage on the stock with an outperform rating and forecasts 30 percent free cash flow CAGR in FY17-19.

    • Buy Ceat, Cipla, Siemens, Ajanta Pharma, Ipca Labs: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests buying Ceat, Cipla, Siemens, Ajanta Pharma and Ipca Labs.

    • Here are top trading ideas from Rahul Arora

      In an interview to CNBC-TV18's Prashant Nair and Sumaira Abidi, Rahul Arora, CEO at Nirmal Bang Institutional Equities shared his readings and outlook on market and specific stocks.

    • Here‘s why Deutsche Bank is upbeat on pharmaceutical sector

      Easing regulatory concerns and actions by the US Food and Drug Administration (FDA) will help the sector and improve investor sentiment, Deutsche Bank said in a report.

    • Buy Adani Ports, Arvind; sell Cipla: Sandeep Wagle

      Sandeep Wagle of powermywealth.com suggests buying Adani Ports and Arvind and advises selling Cipla.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347